Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers in allergen immunotherapy: Focus on eosinophilic inflammation.
Kim CK, Callaway Z, Park JS, Pawankar R, Fujisawa T. Kim CK, et al. Among authors: fujisawa t. Asia Pac Allergy. 2024 Mar;14(1):32-38. doi: 10.5415/apallergy.0000000000000129. Epub 2023 Dec 18. Asia Pac Allergy. 2024. PMID: 38482456 Free PMC article. Review.
Clinical Potential of Eosinophil-Derived Neurotoxin in Asthma Management.
Malinovschi A, Rydell N, Fujisawa T, Borres MP, Kim CK. Malinovschi A, et al. Among authors: fujisawa t. J Allergy Clin Immunol Pract. 2023 Mar;11(3):750-761. doi: 10.1016/j.jaip.2022.11.046. Epub 2022 Dec 26. J Allergy Clin Immunol Pract. 2023. PMID: 36581068 Free article. Review.
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma.
Habu T, Kumagai S, Bando H, Fujisawa T, Mishima S, Kotani D, Nakamura M, Hojo H, Sakashita S, Kinoshita T, Yano T, Mitsunaga S, Nishikawa H, Koyama S, Kojima T. Habu T, et al. Among authors: fujisawa t. J Gastroenterol. 2024 May 31. doi: 10.1007/s00535-024-02120-z. Online ahead of print. J Gastroenterol. 2024. PMID: 38819498
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Ikoma T, Matsumoto T, Boku S, Motoki Y, Kinoshita H, Kosaka H, Kaibori M, Inoue K, Sekimoto M, Fujisawa T, Iwai H, Naganuma M, Tanizaki H, Hisamatsu Y, Okada H, Kurata T. Ikoma T, et al. Among authors: fujisawa t. Cancer Immunol Immunother. 2024 May 11;73(7):126. doi: 10.1007/s00262-024-03707-4. Cancer Immunol Immunother. 2024. PMID: 38733406 Free PMC article.
2,168 results